Development Of Novel Co-Processed Excipients for Fast Dissolving Tablets

Co-processed excipients are emerging as a promising solution to address the limitations of traditional single excipients in pharmaceutical formulations. These excipients are developed by combining two or more existing excipients through specialized manufacturing techniques such as spray drying, wet granulation, and hot-melt extrusion. The resulting co-processed excipients offer enhanced functionality, including improved flow properties, compressibility, and disintegration, without any chemical modifications. This review provides a comprehensive overview of co-processed excipients, including their types, methods of preparation, evaluation techniques, advantages, limitations, and regulatory considerations. The article discusses various examples of co-processed excipients, such as combinations of microcrystalline cellulose with other materials like calcium phosphate, carboxymethylcellulose sodium, and alginic acid. The advantages of co-processed excipients include enhanced dissolution, compressibility, dilution potential, and flow characteristics, as well as simplified production processes and cost-effectiveness. However, limitations such as fixed ratios, higher costs, and lack of pharmacopeial acceptance are also addressed. Additionally, this review highlights the potential applications of co-processed excipients in solid oral dosage forms, semi-solid preparations, and parenteral formulations. Emphasize the need for customized excipients that meet safety, performance, and regulatory standards. The article concludes by emphasizing the importance of co-processed excipients in simplifying formulations and reducing production time and costs, making them an attractive option for the pharmaceutical industry.